GB Sciences ( OTCMKTS:GBLX – Get Rating ) is one of 357 public companies in the 'Biotechnology' industry, but how does it contrast to its peers? We will compare GB Sciences to related companies based on the strength of its risk, analyst recommendations, earnings, profitability, valuation, dividends and institutional ownership. Profitability This table compares GB Sciences and its peers' net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets GB Sciences N/A N/A N/A GB Sciences Competitors -3,091.
https://www.dailypolitical.com/2023/06/18/reviewing-gb-sciences-gblx-its-rivals.html#dailypolitical
Sinun täytyy kirjautua sisään ennen kuin voit kommentoida.